Menu Search
Equities

Cellebrite DI Ltd

CLBT:NSQ

Cellebrite DI Ltd

Actions
TechnologyTechnology
  • Price (USD)17.39
  • Today's Change0.14 / 0.81%
  • Shares traded484.66k
  • 1 Year change+130.33%
  • Beta1.5199
Data delayed at least 15 minutes, as of Sep 19 2024 19:46 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Cellebrite DI Ltd had net income deteriorate from a gain of 120.81m to a loss of 81.10m despite revenues that grew 20.12% from 270.65m to 325.11m over the same period.
Gross margin84.19%
Net profit margin-28.51%
Operating margin13.85%
Return on assets-21.03%
Return on equity--
Return on investment-38.22%
More ▼

Cash flow in USDView more

In 2023, Cellebrite DI Ltd increased its cash reserves by 116.23%, or 101.87m. The company earned 102.06m from its operations for a Cash Flow Margin of 31.39%. In addition the company generated 21.77m cash from financing while 22.54m was spent on investing.
Cash flow per share-0.4685
Price/Cash flow per share--
Book value per share-0.1957
Tangible book value per share-0.3741
More ▼

Balance sheet in USDView more

Cellebrite DI Ltd uses little or no debt in its capital structure.
Current ratio1.75
Quick ratio1.71
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.